News + Filings Transactions Holdings
All
13F
13D/G
Other
|
|
Logos Global Management LP
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/18/2023 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 09/28/2022 |
SC 13G
| Logos Global Management LP reports a 7% stake in Allakos Inc. |
| 05/02/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 03/18/2022 |
SC 13G
| Logos Global Management LP reports a 6.9% stake in IDEAYA Biosciences, Inc. |
| 12/27/2021 |
SC 13G
| Logos Global Management LP reports a 5.6% stake in Harpoon Therapeutics, Inc. |
| 12/02/2021 |
SC 13G
| Logos Global Management LP reports a 3.4% stake in Compass Pathways plc |
| 11/15/2021 |
SC 13G
| Logos Global Management LP reports a 3.3% stake in Atreca, Inc. |
| 09/13/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 08/16/2021 |
SC 13G
| Logos Global Management LP reports a 7.6% stake in Dyne Therapeutics, Inc. |
| 08/13/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 07/28/2021 |
SC 13G
| Logos Global Management LP reports a 6.2% stake in Bicycle Therapeutics plc |
| 07/28/2021 |
SC 13G
| Logos Global Management LP reports a 5.2% stake in Kezar Life Sciences, Inc. |
| 11/09/2020 |
SC 13G
| Logos Global Management LP reports a 15.7% stake in Novus Therapeutics, Inc. |
| 11/09/2020 |
SC 13G
| Logos Global Management LP reports a 8.8% stake in Miragen Therapeutics, Inc. |
| 10/22/2020 |
SC 13G
| Logos Global Management LP reports a 4.3% stake in Celldex Therapeutics, Inc. |
| 09/08/2020 |
SC 13G
| Logos Global Management LP reports a 5% stake in Unum Therapeutics, Inc. |
| 09/01/2020 |
SC 13G
| Logos Global Management LP reports a 5.9% stake in Nkarta, Inc. |
| 08/31/2020 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
|
|